NEUROMUSCULAR DISORDERS
Scope & Guideline
Elevating the standard of care through scientific excellence.
Introduction
Aims and Scopes
- Genetic and Molecular Mechanisms:
Research on the genetic underpinnings of neuromuscular disorders, including identification of novel mutations and understanding their phenotypic implications. - Clinical Trials and Therapeutic Interventions:
Investigation of new treatment modalities, including gene therapies, pharmacological interventions, and their efficacy in clinical settings. - Diagnostic Approaches and Biomarkers:
Development and validation of diagnostic tools and biomarkers for early detection and monitoring of neuromuscular diseases. - Natural History Studies:
Longitudinal studies that track disease progression, clinical features, and outcomes in diverse patient populations. - Patient-Centered Research:
Focus on quality of life, psychosocial aspects, and patient-reported outcomes to inform clinical practices and improve care. - Multidisciplinary Approaches:
Integration of various specialties such as genetics, neurology, rehabilitation, and psychosocial support to address the complex needs of patients.
Trending and Emerging
- Gene Therapy and Advanced Therapeutics:
A surge in publications regarding gene therapy approaches, including innovative strategies for delivering therapies and assessing their long-term effects. - Patient-Centered Outcomes and Quality of Life:
Increasing emphasis on studies that explore patient-reported outcomes, quality of life, and the psychosocial impact of neuromuscular disorders. - Multimodal Imaging Techniques:
The integration of advanced imaging modalities, such as MRI and ultrasound, to assess muscle structure and function, providing valuable insights into disease progression. - Artificial Intelligence and Machine Learning:
Emerging interest in applying AI and machine learning techniques to analyze clinical data and improve diagnostic accuracy and treatment efficacy. - Natural History and Longitudinal Studies:
Growing focus on comprehensive natural history studies that track disease progression over time, contributing to a better understanding of various neuromuscular disorders. - Telemedicine and Remote Monitoring:
The rise of telemedicine and digital health tools for monitoring patients with neuromuscular disorders, especially highlighted during the COVID-19 pandemic.
Declining or Waning
- Traditional Electrophysiology:
The reliance on traditional electrophysiological studies has diminished as newer, more advanced diagnostic techniques, such as genetic testing and imaging, have gained prominence. - Basic Science Research:
There appears to be a decline in purely basic science research focused on muscle biology, as the journal increasingly emphasizes translational and clinical studies. - Descriptive Epidemiological Studies:
While still relevant, the frequency of purely descriptive studies on the epidemiology of neuromuscular disorders has decreased, with a shift towards studies that incorporate clinical outcomes and patient experiences. - Animal Models in Early Research:
The use of animal models for initial drug testing and understanding disease mechanisms is being overshadowed by human-centric studies and patient-derived models. - Single Disease Focus Publications:
There has been a waning interest in studies focusing solely on one specific neuromuscular disorder, as the journal increasingly seeks to address broader themes that encompass multiple disorders.
Similar Journals
KLINISCHE NEUROPHYSIOLOGIE
Pioneering novel approaches in clinical neurophysiology.KLINISCHE NEUROPHYSIOLOGIE is a pivotal journal dedicated to advancing the field of clinical neurophysiology, published by GEORG THIEME VERLAG KG in Germany. With an ISSN of 1434-0275 and an E-ISSN of 1439-4081, this journal aims to disseminate high-quality research findings that enhance our understanding of neurological disorders and their physiological underpinnings. Although currently positioned in the fourth quartile in both Neurology (clinical) and Physiology (medical) categories, the journal offers a unique platform for novel insights and empirical studies, filling a crucial niche within the medical community. Researchers, healthcare professionals, and students can benefit from its Open Access option, which promotes wider accessibility and engagement with cutting-edge scientific discourse. As the journal converges through the years from 1998 to 2024, it remains committed to fostering scholarly collaboration and innovation in neurophysiological research, crucial for improving clinical outcomes.
Neurology Research International
Elevating Knowledge in Neurological ScienceNeurology Research International, published by HINDAWI LTD, is an esteemed open access journal that has been serving the neurology community since 2010. With its ISSN 2090-1852 and E-ISSN 2090-1860, this journal aims to foster knowledge dissemination and facilitate dialogue surrounding key issues in neurology and clinical neuroscience, making it a vital resource for researchers, clinicians, and students alike. It operates from the United States, with its administrative hub located in London, England. As of 2023, the journal has been positioned in the Q3 category for both neurology and clinical neurology, reflecting its commitment to advancing research within these critical fields. With a current Scopus rank of #216/400 in clinical neurology and a #113/192 in neuroscience, and a converged publication timeline from 2010 to 2024, Neurology Research International is dedicated to promoting high-quality research that addresses contemporary challenges and innovations in neurological science. By offering open access since its inception, it ensures that cutting-edge research is freely available, aligning with the global push towards accessible scientific communication.
JOURNAL OF ENDOCRINOLOGY
Pioneering Research in Endocrine HealthJOURNAL OF ENDOCRINOLOGY, established in 1946 and published by BIOSCIENTIFICA LTD, stands as a premier scholarly outlet in the field of endocrinology, diabetes, and metabolism. With an impressive H-Index reflecting its significant contribution to the literature, this journal maintains a strong presence in academic circles, evidenced by its Q1 ranking in the 2023 Scopus categories for both Endocrinology and Diabetes and Metabolism. With its targeted scope serving a global audience of researchers, professionals, and students, it provides a vital platform for disseminating innovative research findings and advancing the scientific understanding of endocrine systems. As we approach its convergence year of 2024, JOURNAL OF ENDOCRINOLOGY remains committed to publishing high-quality, peer-reviewed articles that explore cutting-edge developments in the field, thereby impacting clinical practices and guiding future research directions.
NEUROGENETICS
Illuminating the Genetic Foundations of Neural HealthNEUROGENETICS is a distinguished journal published by SPRINGER, focusing on the intersection of genetics and neuroscience. With its ISSN 1364-6745 and E-ISSN 1364-6753, this journal has been a vital resource in the fields of cellular and molecular neuroscience and genetics since its establishment in 1997. As of 2023, it is ranked Q3 in Cellular and Molecular Neuroscience and Q2 in both Genetics and Clinical Genetics, reflecting its growing influence and importance in these areas. Although not an open-access journal, it provides significant insights and research findings that contribute to advancing our understanding of genetic influences on neural function and disease. Based in Germany with an address at ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES, NEUROGENETICS serves as a crucial platform for researchers, professionals, and students alike to explore innovative studies that are essential for the future of neuroscience and genetics. With its continuous commitment to high-quality research, the journal aims to foster collaboration and knowledge dissemination among the scientific community.
CLINICAL NEUROLOGY AND NEUROSURGERY
Advancing Neurological Insights for Tomorrow's CareCLINICAL NEUROLOGY AND NEUROSURGERY, published by Elsevier, is a pivotal journal in the fields of neurology and neurosurgery, recognized for its rigorous peer-review process and commitment to advancing clinical practices. Established in 1974, the journal has become a respected source of innovative research, evidenced by its excellent Scopus rankings—placing it within the top half of journals in both Medicine (Surgery) and the clinical aspect of Neurology. Notably, it has achieved a Q2 ranking in both Medicine (miscellaneous) and Surgery, and Q3 in Neurology (clinical) as of 2023. The journal publishes a wide array of articles focused on the latest findings, clinical practices, and technological advancements that address neurological disorders and surgical interventions. While it does not currently operate under an open-access model, it remains highly accessible to academic institutions and professionals worldwide from its editorial base in the Netherlands. By enabling knowledge-sharing and fostering collaboration among researchers, practitioners, and students, CLINICAL NEUROLOGY AND NEUROSURGERY plays a crucial role in shaping the future of clinical neurology and surgical techniques.
DYSPHAGIA
Cutting-edge Insights into Swallowing DisordersDYSPHAGIA, published by Springer, is a premier journal dedicated to advancing the study of swallowing disorders, a critical area within the fields of Gastroenterology, Otorhinolaryngology, and Speech and Hearing. With an ISSN of 0179-051X and E-ISSN 1432-0460, this journal serves as a vital resource for researchers, clinicians, and students alike, providing cutting-edge research and reviews that inform clinical practice and enhance patient care. As a testament to its influence, DYSPHAGIA holds a Q2 ranking in Gastroenterology and Q1 rankings in both Otorhinolaryngology and Speech and Hearing for 2023. Its Scopus rankings further position it among the leading journals in its field, highlighting its importance and impact within the academic community. The journal publishes contributions that encompass a spectrum of topics related to swallowing, making it an essential platform for disseminating knowledge and fostering innovative solutions in the management of dysphagia. Operating from New York, NY, DYSPHAGIA invites contributions that align with its mission to advance the understanding and treatment of swallowing disorders through rigorous scientific inquiry and discourse.
Multiple Sclerosis and Related Disorders
Advancing knowledge in neurology and multiple sclerosis.Multiple Sclerosis and Related Disorders, published by Elsevier Science Ltd, is a leading journal that serves as a vital resource in the field of neurology, particularly focused on multiple sclerosis and its associated conditions. This esteemed journal, which holds a Q1 ranking in Medicine (miscellaneous) and Q2 ranking in both Neurology and Clinical Neurology, delivers high-impact research findings and clinical insights crucial for advancing the understanding and management of multiple sclerosis. With an ISSN of 2211-0348 and an E-ISSN of 2211-0356, it provides valuable content from 2012 to 2024 aimed at researchers, healthcare professionals, and students dedicated to improving patient outcomes and fostering innovative strategies in treatment. Additionally, the journal's presence in the Scopus rankings highlights its relevance and influence in the academic community, ranking 121 out of 400 in Clinical Neurology and 59 out of 192 in Neuroscience. This comprehensive platform encourages the dissemination of cutting-edge knowledge and clinical practices, making it an essential tool for those committed to the field of neurology and related research.
PRACTICAL NEUROLOGY
Connecting Theory and Practice in the Field of NeurologyPRACTICAL NEUROLOGY, published by the esteemed BMJ PUBLISHING GROUP, is a prominent journal in the fields of neurology and medicine, significantly impacting clinical practice since its inception in 2001. With an ISSN of 1474-7758 and an e-ISSN of 1474-7766, this UK-based journal reaches a diverse audience of researchers, clinicians, and students who seek to advance their understanding of neurological conditions and patient care strategies. Ranked in the second quartile (Q2) in both the miscellaneous medicine and clinical neurology categories for 2023, and positioned in the 47th percentile among its peers, PRACTICAL NEUROLOGY provides a platform for high-quality research that bridges the gap between laboratory findings and clinical applications. The journal's commitment to disseminating valuable information through peer-reviewed articles ensures that readers are equipped with the latest insights and practical knowledge necessary for improving outcomes in neurology. While access options are not currently open, the journal remains a vital resource for professionals striving to stay at the forefront of neurological research and clinical practice.
Neurology and Clinical Neuroscience
Exploring innovative solutions in neurological health.Neurology and Clinical Neuroscience, published by WILEY, is a pivotal peer-reviewed journal dedicated to advancing knowledge in the fields of neurology and clinical neuroscience. With an ISSN of 2049-4173, it encompasses a diverse range of topics related to neurological disorders, offering a platform for groundbreaking research and clinical practices. Although the journal does not currently operate under an open access model, it aims to foster an inclusive academic environment by providing high-quality content that is accessible to both specialists and general practitioners in the medical community. Despite its relatively recent establishment from 2013 to 2024, the journal has gained recognition with Scopus rankings highlighting its role in clinical neurology and neuroscience spheres. It serves as an essential resource for researchers, professionals, and students seeking to expand their understanding and engage in current discussions surrounding neurological health and diseases.
Neurodegenerative Diseases
Elevating research on the spectrum of neurodegeneration.Neurodegenerative Diseases, published by KARGER, is a prominent academic journal dedicated to advancing the field of neurology and neuroscience. With an ISSN of 1660-2854 and E-ISSN 1660-2862, this journal serves as a vital platform for researchers, professionals, and students engaged in the exploration of neurodegenerative disorders from various perspectives, including clinical applications and therapeutic interventions. Spanning two decades since its inception in 2004 and set to converge in 2024, it has steadily built a reputation within the academic community, achieving a commendable Q2 ranking in clinical neurology and Q3 in general neurology according to the 2023 category quartiles. The journal boasts an impressive Scopus rank of 114/400 (71st percentile) in clinical neurology and 58/192 (70th percentile) in neuroscience neurology. While not classified as open access, the publication provides critical insights into the latest research and developments, making it an essential resource for anyone dedicated to understanding and combating neurodegenerative diseases.